Amit Sachdev

CIK 1406338 · EVP Chief Patient & Ext Af Off · last filed 2026-02-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$28.86M

Companies

2

Total Filings

146

Lifetime Open-Market Net

-$171.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VRTX EVP Chief Patient & Ext Af Off 64,871 $444.93 $28.86M -$171.36M 141 2026-02-26
Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Director 16,000 $1.73 $27.6K $0 5 2023-03-03

Recent Filings · Page 3 of 15

146 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-08-14 VRTX Sell (S) −10,031 -$3.51M EDGAR
2023-03-03 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Grant (A) $0 EDGAR
2023-02-28 VRTX Tax (F) −2,468 -$713.5K EDGAR
2023-02-22 VRTX Tax (F) −3,498 -$1.02M EDGAR
2023-02-14 VRTX Tax (F) −7,268 -$2.16M EDGAR
2023-02-03 VRTX Mixed +24,728 $0 EDGAR
2022-03-11 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Grant (A) +6,000 $0 EDGAR
2022-02-28 VRTX Tax (F) −7,368 -$1.68M EDGAR
2022-02-22 VRTX Tax (F) −3,497 -$813.1K EDGAR
2022-02-14 VRTX Tax (F) −2,491 -$592.2K EDGAR
Showing 2130 of 146
Page 3 of 15
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.